Vitamin K1 enhances sorafenib-induced growth inhibition and apoptosis of human malignant glioma cells by blocking the Raf/MEK/ERK pathway
<p>Abstract</p> <p>Background</p> <p>The combined effects of anticancer drugs with nutritional factors against tumor cells have been reported previously. This study characterized the efficacy and possible mechanisms of the combination of sorafenib and vitamin K1 (VK1) o...
Main Authors: | Du Wei, Zhou Jing-ru, Wang Dong-liang, Gong Kai, Zhang Qing-jun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-04-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | http://www.wjso.com/content/10/1/60 |
Similar Items
-
Lensoside Aβ as an Adjuvant to the Anti-Glioma Potential of Sorafenib
by: Aleksandra Maciejczyk, et al.
Published: (2021-05-01) -
Metformin Enhances the Anti-Cancer Efficacy of Sorafenib via Suppressing MAPK/ERK/Stat3 Axis in Hepatocellular Carcinoma
by: Sumit Siddharth, et al.
Published: (2022-07-01) -
Sorafenib targets and inhibits the oncogenic properties of endometrial cancer stem cells via the RAF/ERK pathway
by: Tomoka Takao, et al.
Published: (2022-06-01) -
PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation
by: Xiaojuan Wang, et al.
Published: (2020-08-01) -
Synergistic growth inhibition by sorafenib and vitamin K2 in human hepatocellular carcinoma cells
by: Yafei Zhang, et al.
Published: (2012-09-01)